Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersRadiation Oncology Physician in Madison, WI
NPI: 1053576926Primary Practice Location
SSM Health Cancer Center
1104 John Nolen Dr, Madison, WI
Primary Employer
SSM Health Cancer Center
ssmhealth.com
HQ Phone
Get M.D. Timothy's Phone NumberMobile
Get M.D. Timothy's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
WI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77336Radiation therapy consultation per week | 76 | 282 |
| 2 | 77014Ct scan guidance for insertion of radiation therapy fields | 75 | 843 |
| 3 | 77427Radiation treatment management, 5 treatment sessions | 74 | 264 |
| 4 | 77300Calculation of radiation therapy dose | 73 | 188 |
| 5 | 77263Complex radiation therapy planning | 72 | 77 |
Advancements in unresectable melanoma: a multidisciplinary perspective.
Authors: Jeffrey Sosman, Mary Martini, Jeffrey Wayne, Maria Colavincenzo, Sunandana Chandra, Kurt Lu, Timothy Kuzel, Jeffrey Wayne
Journal: Melanoma Manag
Publication Date: 2016-08-16
Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer.
Authors: Michelle Gentile, Comron Hassanzadeh, Nisha Mohindra, Timothy Sita, Clifford Robinson, Pamela Samson, Michael Roach, Saiama Waqar
Publication Date: 2020-12-07
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutation.
Authors: Adithya Chennamadhavuni, Nanmeng Yu, Muhammad Furqan, Lawrence Feldman, Timothy Sita, Melissa Yan
Journal: Transl Lung Cancer Res
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, RADIATION: Prophylactic Cranial Irradiation
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Pembrolizumab, RADIATION: Stereotactic Body Radiation Therapy
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Docetaxel, DRUG: Pembrolizumab, DRUG: Gemcitabine, DRUG: Pemetrexed Disodium, DRUG: Erlotinib Hydrochloride, RADIATION: Stereotactic Body Radiation Therapy (SBRT), RADIATION: Intensity-Modulated Radiation Therapy (IMRT), RADIATION: 3-Dimensional Conformal Radiation Therapy (3D-CRT)
